Beyond Antioxidants: The Emerging Role of Nrf2 Activation in Amyotrophic Lateral Sclerosis (ALS). [PDF]
Sharbafshaaer M +7 more
europepmc +1 more source
Systematic Review of the Huntington's Disease Drug Development Pipeline, 2014 to 2025
Abstract Background In the past decade, significant advances have improved our understanding of the mechanisms underlying HD pathobiology leading to several putative therapeutic targets for HD. Objective The aim was to describe the Huntington's disease (HD) drug development clinical pipeline.
Pavlina Konstantinova +5 more
wiley +1 more source
Symptom-Level Precision Neurology in Amyotrophic Lateral Sclerosis (ALS): Linking Microglial Pruning, Mitochondrial Nicotinamide Adenine Dinucleotide (NAD+) Compensation, and Autophagy Failure Across the Aging Spectrum. [PDF]
Cheung N.
europepmc +1 more source
ABSTRACT Purpose Increase clinical acceptance of MRE and DTI by shortening the scan time by half and providing diffusive and mechanical property maps that are inherently co‐registered. This proof‐of‐concept study evaluates the simultaneous DTI‐MRE acquisition in the human brain and compares its results to conventional DTI and MRE measurements.
Shujun Lin +4 more
wiley +1 more source
Stage-Based Communication Rehabilitation in Amyotrophic Lateral Sclerosis (ALS): A Review of Strategies for Enhancing Quality of Life. [PDF]
Jackson MC +3 more
europepmc +1 more source
SNR‐Efficient Inhomogeneous Magnetization Transfer (ihMT) for Clinical Applications at 7 T
ABSTRACT Purpose Inhomogeneous MT (ihMT) is an MRI modality sensitive to Myelin, the lipid‐rich membrane surrounding the axons. A novel ihMT saturation strategy and its associated B1+$$ {\mathrm{B}}_1^{+} $$ correction at UHF are proposed. The aim is to generate a strong ihMT effect within a clinically compatible scan time while complying with SAR ...
Timothy Anderson +8 more
wiley +1 more source
Greek Registry for Amyotrophic Lateral Sclerosis (ALS-GR): An Observational Cohort of Individuals With ALS Across 11 Specialized Centers in Greece. [PDF]
Liampas I +29 more
europepmc +1 more source
ABSTRACT Congenital myasthenic syndromes (CMS) are inherited disorders caused by mutations in genes encoding proteins essential for neuromuscular junction (NMJ) function. Pathogenic variants have been identified in more than 35 genes, underscoring the complexity of synaptic biology and the wide range of mechanisms that can compromise neuromuscular ...
Rocio‐Nur Villar‐Quiles +5 more
wiley +1 more source
To Treat or Not to Treat: A Scoping Review of Speech Treatment for Dysarthria in Amyotrophic Lateral Sclerosis (ALS). [PDF]
Whelan BM +13 more
europepmc +1 more source

